Abiopharma

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in November

Kymera Therapeutics to Participate in Upcoming November Investor Conferences

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update

Glaukos Announces Participation in Upcoming Investor Conferences

Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)

Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress